Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies i
about
Foxp3 represses retroviral transcription by targeting both NF-kappaB and CREB pathwaysQuantification of the virus-host interaction in human T lymphotropic virus I infection.Immunopathogenesis and neurological manifestations associated to HTLV-1 infectionTreatment of HTLV-I-Associated Myelopathy / Tropical Spastic Paraparesis: Towards Rational Targeted TherapyEpigenetic modification of the FoxP3 TSDR in HAM/TSP decreases the functional suppression of Tregs.Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis.Selection of human antibody fragments directed against tumor T-cell epitopes for adoptive T-cell therapy.Abnormally high levels of virus-infected IFN-gamma+ CCR4+ CD4+ CD25+ T cells in a retrovirus-associated neuroinflammatory disorder.Immunogenetics and the Pathological Mechanisms of Human T-Cell Leukemia VirusType 1- (HTLV-1-)Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).HLA class I binding of HBZ determines outcome in HTLV-1 infection.Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease.A novel T-cell receptor mimic defines dendritic cells that present an immunodominant West Nile virus epitope in mice.HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death.Expansion in CD39⁺ CD4⁺ immunoregulatory t cells and rarity of Th17 cells in HTLV-1 infected patients is associated with neurological complications.Control of the inflammatory response mechanisms mediated by natural and induced regulatory T-cells in HCV-, HTLV-1-, and EBV-associated cancers.Inhibition of immune activation by a novel nuclear factor-kappa B inhibitor in HTLV-I-associated neurologic disease.Distinct expression profiles of TGF-beta1 signaling mediators in pathogenic SIVmac and non-pathogenic SIVagm infections.Myocyte enhancer factor (MEF)-2 plays essential roles in T-cell transformation associated with HTLV-1 infection by stabilizing complex between Tax and CREBHuman T-lymphotropic virus type 1 (HTLV-1) and regulatory T cells in HTLV-1-associated neuroinflammatory disease.CD4(+)CD25(High) Treg cells in HIV/HTLV co-infected patients with neuropathy: high expression of Alpha4 integrin and lower expression of Foxp3 transcription factor.CADM1/TSLC1 Identifies HTLV-1-Infected Cells and Determines Their Susceptibility to CTL-Mediated Lysis.T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy.Natural regulatory T cells and persistent viral infection.Regulatory T cells in virus infections.Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individualsDysregulation of TGF-beta signaling and regulatory and effector T-cell function in virus-induced neuroinflammatory disease.Novel antibodies as anticancer agents.Lack of recall response to Tax in ATL and HAM/TSP patients but not in asymptomatic carriers of human T-cell leukemia virus type 1.Presentation of human T cell leukemia virus type 1 (HTLV-1) Tax protein by dendritic cells: the underlying mechanism of HTLV-1-associated neuroinflammatory disease.Neuroimmunity of HTLV-I Infection.The tug-of-war between dendritic cells and human chronic viruses.T-cell-receptor-like antibodies - generation, function and applications.Molecular and clinical effects of betamethasone in human T-cell lymphotropic virus type-I-associated myelopathy/tropical spastic paraparesis patients.How does HTLV-I persist despite a strong cell-mediated immune response?A tax on luxury: HTLV-I infection of CD4+CD25+ Tregs.Impairment of the humoral and CD4(+) T cell responses in HTLV-1-infected individuals immunized with tetanus toxoid.Reduction of human T-cell leukemia virus type-1 infection in mice lacking nuclear factor-kappaB-inducing kinase.Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM/TSP.A genetic IFN/STAT1/FAS axis determines CD4 T stem cell memory levels and apoptosis in healthy controls and Adult T-cell Leukemia patients.Adult T-cell leukemia/lymphoma cells from blood and skin tumors express cytotoxic T lymphocyte-associated antigen-4 and Foxp3 but lack suppressor activity toward autologous CD8+ T cells
P2860
Q24323279-AD01191B-E9E3-49DC-A9D3-BCE79301E1F6Q25257600-5AF21588-7705-471E-9F19-818E7A0D48A1Q27026230-AA556B66-09E2-452F-ADF8-68DD429F7C1CQ28972318-06EB4B10-405D-44D3-8A86-4850615C5621Q30371156-73963909-B0BE-4E29-AEB8-EDBE646345C7Q31033564-C974B87F-A660-4287-BF88-0FC2A7F40A20Q33368725-530B9875-31EA-4A2A-8F62-269BF976238BQ33490596-A15B4B6B-8CC1-4D6B-AC99-10681B3C8687Q33651831-E72006A0-3B07-4A09-AE8F-E6F6067BE031Q33707746-43C3DBCC-43D5-4023-A25C-08899CE61A24Q33768325-46B1A602-85C8-4089-A585-6FA8D0B69994Q33934227-58DFC82C-66A8-412E-9E0C-19F6AFCC2823Q34498932-534C48BC-E156-4444-BAFA-8C98F4E02CC5Q34587031-F5E6D68C-A69B-45C5-BAB0-F464A95D69EDQ34708248-E5A6C881-7414-4099-8DBC-4CD0257E5F76Q34754386-DAEF50C4-A6AE-486F-8A05-73E5F677085DQ34944988-2FF1A703-08A6-4D36-8908-93835B5BB0FDQ35218631-2130813C-F32A-438B-BC84-75BB2BDC2713Q35276727-734E5B54-3AE7-49C9-92CB-520B407677DDQ35761598-CBA29AFB-A71F-4076-B17B-6A5ED26205F1Q35997030-A0574D9E-2798-4E3F-B5F3-32C357AD2C36Q36297606-2AB0FAB2-F791-48E3-8B1A-06F9BFCE1D1CQ36423940-15917F1E-9C04-4262-B89A-BED00C11370FQ36563550-F0E0C42C-47E2-40D5-9E50-99E3FB5A9CEDQ36646919-8E1D80C6-E106-4B3C-8EF8-C2D777EF65CCQ36713538-F0527D52-5435-4DA7-97D0-B6CC729D7E03Q36832141-ED2949C2-B914-47CF-AD6A-A10C9452C77FQ37200968-31682321-2610-473A-95D8-3F9B7C1B2C0BQ37415520-F4538F88-05B2-404A-864C-A7E3FCEB23A8Q37741036-BD3E998A-AD5E-4404-BF66-E2725E04F811Q37952807-AB1C10EF-C555-44E1-ACDE-DC453967658CQ37987723-4843332B-DD66-4FE0-BDDE-D157D6EF26BEQ38867574-5698BC6F-2C00-4CD0-803F-C94B07E48147Q38882231-FE73DC5E-4FC0-4E72-9F3F-C816D8CF417DQ39013646-2A5A09B7-180F-4C9D-98C8-C45AF55D1A4CQ39481246-29DDCFC1-6987-4ACD-A1A1-B2F099839D78Q45396790-8DE18862-0D1A-4BCC-A4C7-E0CC02FED02CQ47201640-F9BAAB2F-82CC-40E7-AF33-E50B014CD070Q55231926-AA4DEDDC-46F3-4E34-97B8-E54C07074956Q56900883-204A375E-36B1-4271-9834-80C08D0AFF19
P2860
Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies i
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Increased expression of human ...... omplex-restricted antibodies i
@ast
Increased expression of human ...... omplex-restricted antibodies i
@en
type
label
Increased expression of human ...... omplex-restricted antibodies i
@ast
Increased expression of human ...... omplex-restricted antibodies i
@en
prefLabel
Increased expression of human ...... omplex-restricted antibodies i
@ast
Increased expression of human ...... omplex-restricted antibodies i
@en
P2093
P2860
P921
P356
P1476
Increased expression of human ...... omplex-restricted antibodies i
@en
P2093
Cyril J Cohen
Hong-Chuan Li
Norihiro Takenouchi
Steven Jacobson
Utano Tomaru
Yoram Reiter
Yoshihisa Yamano
P2860
P304
P356
10.1084/JEM.20032042
P407
P577
2004-05-10T00:00:00Z